Ozuriftamab

• Description:

  Ozuriftamab is a human IgG1 kappa antibody of ROR2. Ozuriftamab can be used to synthesize ADC such as Ozuriftamab vedotin (HY-145627) . Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) [1].

• Product Name Alternative:

  BA302

• UNSPSC:

  12352203

• Target:

  ADC Antibody; ROR

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Antibody-drug Conjugate/ADC Related; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/ozuriftamab.html

• Purity:

  99.73

• Solubility:

  10 mM in DMSO

• Smiles:

  [Ozuriftamab]

• Molecular Weight:

  (146.5 kDa)

• References & Citations:

  [1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 35, No. 4, 2021.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  Store at -80°C for 2 years

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  Phase 2

• CAS Number:

  [2460399-44-2]